Spyre Therapeutics(SYRE)
WALTHAM, MABiotechnology
Focus: Spyre Therapeutics is a publicly traded antibody-focused biotechnology company headquartered in Waltham, MA, specializing in immunology therapeutics. The company is in early-stage clinical development with no approved products generating minimal revenue.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1-4 this month
Stable — net -4 jobs in 30d
1 added, 5 removed. Backfill posture.
Should You Work at Spyre Therapeutics?
AI assessmentHigh-risk, high-upside early-stage play suitable only for scientists/operators comfortable with startup volatility and willing to bet on antibody biology in immunology.
Why Work Here
- Early-stage antibody platform with greenfield opportunity to shape foundational science in immunology before market inflection
- Public company status provides liquidity and potential equity upside without early-stage dilution risks of private funding rounds
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$886K
Pipeline & Clinical Trials
SPY002-091
HealthyClinical Trials (1)
NCT06672718A Study of SPY002-091 in Healthy Volunteers
Phase 1Help build intelligence for Spyre Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.